Work

Correction: Prediction of personalized antiseizure medications response based on clinical signatures in epilepsy

Year: 2026

Type: erratum

Abstract: Additionally, “The AUCs of common dual regimens were 0.543 for levetiracetam + oxcarbazepine, 0.454 for levetiracetam + valproate, and 0.583 for levetiracetam + lamotrigine. Levetiracetam + carbamazepine showed the highest AUC, 0.686.”

Source: Scientific Reports

DOI: 10.1038/s41598-026-37481-3

Authors: Kyung-Il Park, Youmin Shin, Sungeun Hwang, Yong-Jeong Kim, Yong-Jeong Kim, Seung-Bo Lee, Seung-Bo Lee, Hyoshin Son, Jangsup Moon, Soon-Tae Lee, Soon-Tae Lee, Keun-Hwa Jung, Kon Chu, Ki-Young Jung, Young-Gon Kim, Young-Gon Kim, Sang Kun Lee, Sang Kun Lee

Institutions: Seoul National University, Seoul National University Hospital, Ewha Womans University Mokdong Hospital, Keimyung University, The Catholic University of Korea Eunpyeong St. Mary's Hospital, Catholic University of Korea

Language: English

Topic: Epilepsy research and treatment

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,690

OpenAlex ID: W7127125018

Cites:

Cited by:

Related to: